Crinetics Pharmaceuticals Inc (CRNX) Ownership

43.32 ↓0.90 (-2.04%)
As of April 24, 2024, 3:59pm EST.

Institutional Ownership

BlackRock Inc is the biggest individual institutional holder of Crinetics Pharmaceuticals Inc (CRNX), owning a total of 5.3 million shares. Combined, the top 31 institutional holders of CRNX own 89.27% of the company with a total of 65 million shares.

In the latest ownership report on December 31st 2023, the top 31 institutional holders increased their combined ownership of CRNX by 5.4 million shares. 14 institutions bought 7,470,858 total additional shares and increased their ownership by an average of 34.44%. However 5 institutions sold 2,063,841 total shares and decreased their ownership by an average of 17.17%.

Overall this is a positive sign as the number of shares owned by the top 20 institutional holders of Crinetics Pharmaceuticals increased by a net total of 5,407,017 in the latest quarter.

Institution Ownership Chart

Your browser does not support this chart.

Latest Institutional Ownership Changes

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
BlackRock Inc6.859%10.306%5,345,114499,3972023-12-31
Driehaus Capital Management LLC6.467%-1.799%5,039,957-92,3302023-12-31
FMR Inc5.189%88.890%4,043,8651,903,0042023-12-31
State Street Corporation4.573%24.924%3,563,736711,0162023-12-31
Vanguard Group Inc4.494%2.801%3,502,45295,4172023-12-31
Wellington Management Company LLP4.164%-10.855%3,245,105-395,1302023-12-31
T. Rowe Price Associates, Inc.3.861%16.704%3,008,858430,6592023-12-31
Jennison Associates LLC3.269%77.701%2,547,6831,113,9922023-12-31
T. Rowe Price Investment Management,Inc.3.102%47.346%2,417,493776,8012023-12-31
Paradigm Biocapital Advisors LP2.968%6.159%2,312,919134,1822023-12-31
EcoR1 Capital, LLC2.583%31.515%2,012,517482,2542023-12-31
First Light Asset Management, LLC2.551%25.544%1,987,772404,4432023-12-31
Orbimed Advisors, LLC2.140%-42.427%1,667,360-1,228,7142023-12-31
Geode Capital Management, LLC1.736%6.537%1,352,67282,9982023-12-31
Goldman Sachs Group Inc1.669%135.315%1,300,346747,7482023-12-31
Perceptive Advisors LLC1.611%-0.651%1,255,512-8,2202023-12-31
Cormorant Asset Management, LLC1.476%4.365%1,150,00048,0962023-12-31
Novo A/S1.412%0.000%1,100,00002023-12-31
Eventide Asset Management, LLC1.360%4.010%1,059,63340,8512023-12-31
Saturn V Capital Management LLC1.178%-30.131%787,132-339,4472023-12-31

Top Institutions

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
BlackRock Inc6.859%10.306%5,345,114499,3972023-12-31
Driehaus Capital Management LLC6.467%-1.799%5,039,957-92,3302023-12-31
Point72 Asset Management, L.P.5.422%0.000%4,225,3004,225,3002023-09-30
FMR Inc5.189%88.890%4,043,8651,903,0042023-12-31
State Street Corporation4.573%24.924%3,563,736711,0162023-12-31
Vanguard Group Inc4.494%2.801%3,502,45295,4172023-12-31
Wellington Management Company LLP4.164%-10.855%3,245,105-395,1302023-12-31
T. Rowe Price Associates, Inc.3.861%16.704%3,008,858430,6592023-12-31
Bvf Inc5.005%0.000%2,736,61302023-03-31
Jennison Associates LLC3.269%77.701%2,547,6831,113,9922023-12-31
T. Rowe Price Investment Management,Inc.3.102%47.346%2,417,493776,8012023-12-31
Paradigm Biocapital Advisors LP2.968%6.159%2,312,919134,1822023-12-31
BRAIDWELL LP3.694%-41.790%2,019,714-1,449,9602023-03-31
EcoR1 Capital, LLC2.583%31.515%2,012,517482,2542023-12-31
First Light Asset Management, LLC2.551%25.544%1,987,772404,4432023-12-31
Orbimed Advisors, LLC2.140%-42.427%1,667,360-1,228,7142023-12-31
Geode Capital Management, LLC1.736%6.537%1,352,67282,9982023-12-31
Goldman Sachs Group Inc1.669%135.315%1,300,346747,7482023-12-31
Bain Capital Life Sciences Investors, LLC1.910%-44.675%1,275,552-1,030,0062023-09-30
Perceptive Advisors LLC1.611%-0.651%1,255,512-8,2202023-12-31
Cormorant Asset Management, LLC1.476%4.365%1,150,00048,0962023-12-31
Suvretta Capital Management, LLC2.091%0.000%1,125,1121,125,1122022-06-30
Novo A/S1.412%0.000%1,100,00002023-12-31
Eventide Asset Management, LLC1.360%4.010%1,059,63340,8512023-12-31
Deep Track Capital, LP1.943%-0.396%1,048,829-4,1712022-12-31
5AM Venture Management, LLC1.291%0.000%862,28602023-06-30
Opaleye Management Inc1.265%7.535%845,00059,2062023-06-30
Finepoint Capital LP1.458%-8.164%797,527-70,9002023-06-30
Saturn V Capital Management LLC1.178%-30.131%787,132-339,4472023-12-31
Baker Bros Advisors LP1.367%-11.090%735,716-91,7642022-09-30
Sphera Funds Management Ltd.1.164%6.771%626,55239,7322022-09-30

Mutual Fund Ownership

Vanguard Total Stock Mkt Idx Inv is the biggest individual fund holder of Crinetics Pharmaceuticals Inc (CRNX), owning a total of 2 million shares. Combined, the top 40 mutual fund holders of CRNX own 41.29% of the company with a total of 29.5 million shares.

In the latest ownership report on March 31st 2024, the top 40 fund holders increased their combined ownership of CRNX by 149 thousand shares. 3 funds bought 174,270 total additional shares and increased their ownership by an average of 8.49%. However 1 funds sold 25,303 total shares and decreased their ownership by an average of 3.1%.

Overall this is a positive sign as the number of shares owned by the top 20 mutual funds holding Crinetics Pharmaceuticals increased by a net total of 148,967 in the latest report.

Mutual Funds Chart

Your browser does not support this chart.

Latest Mutual Fund Ownership Changes

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
SPDR® S&P Biotech ETF2.331%0.536%1,816,3379,6902024-03-31
Jennison Health Sciences Equity1.044%20.557%813,503138,7142024-03-31
Bridge Builder Small/Mid Cap Growth1.015%-3.099%791,229-25,3032024-03-31
Jennison SMid Cap Core Equity0.793%4.370%617,80025,8662024-03-31

Top Mutual Funds

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
Vanguard Total Stock Mkt Idx Inv2.524%-0.371%1,967,259-7,3162024-02-29
SPDR® S&P Biotech ETF2.331%0.536%1,816,3379,6902024-03-31
iShares Russell 2000 ETF2.072%0.301%1,614,3734,8492024-03-28
Vanguard Instl Ttl Stck Mkt Idx Tr2.409%19.057%1,609,013257,5442023-03-31
Fidelity Select Biotechnology1.814%0.000%1,413,65002024-02-29
T. Rowe Price New Horizons1.706%-0.319%1,329,330-4,2482023-12-31
US Small-Cap Growth II Equity Comp1.706%-0.319%1,329,330-4,2482023-12-31
Fidelity® Select Biotechnology1.846%-9.960%1,233,050-136,4002023-11-30
Eventide Healthcare & Life Sciences I1.360%4.010%1,059,63340,8512023-12-31
Vanguard Institutional Extnd Mkt Idx Tr1.098%0.513%855,5054,3642024-02-29
Jennison Health Sciences Equity1.044%20.557%813,503138,7142024-03-31
Bridge Builder Small/Mid Cap Growth1.015%-3.099%791,229-25,3032024-03-31
T. Rowe Price US Small-Cap Core Equity1.005%-0.140%783,032-1,1002023-12-31
T. Rowe Price Small-Cap Stock1.005%-0.140%783,032-1,1002023-12-31
PGIM Jennison Health Sciences Z0.866%0.000%674,78902024-02-29
Fidelity Small Cap Index0.848%1.718%660,83011,1632024-01-31
Fidelity® Small Cap Index0.932%2.767%622,82916,7712023-10-31
Vanguard Extended Market Index Investor1.134%-0.028%619,920-1742023-08-31
Jennison SMid Cap Core Equity0.793%4.370%617,80025,8662024-03-31
PGIM Jennison Small Company A0.765%0.000%596,11802024-02-29
Destinations Multi Strategy Alts I1.082%0.000%591,80502023-08-31
Fidelity Advisor Biotechnology I0.740%0.000%576,30002024-02-29
Fidelity Advisor® Biotechnology I0.863%15.762%576,30078,4692023-11-30
MEDICAL BioHealth EUR Acc0.833%0.000%556,36502023-09-30
Heptagon Driehaus US Micro Cap Eq C$ Acc0.688%0.000%535,80402024-02-29
iShares Biotechnology ETF0.669%8.558%521,53341,1132024-03-28
iShares Russell 2000 Value ETF0.663%-0.064%516,541-3282024-03-28
Fidelity Small Cap Value Fund0.718%0.000%500,00002023-12-31
Fidelity® Small Cap Value0.749%0.000%500,000500,0002023-10-31
BNP Paribas Health Cr Innovtr Cl Cap0.654%0.015%436,676642023-11-30
Fidelity® Series Large Cap Stock0.724%0.000%389,80002022-12-31
T. Rowe Price U.S. SC Core Eq Tr-Z0.556%60.132%371,235139,4052023-09-30
State St Russell Sm/Mid Cp® Indx NL Cl C0.661%32.504%361,18688,6002023-09-30
Wellington Global Hlthcr Eq USD G Ac0.626%-3.463%342,476-12,2852023-08-31
Driehaus Event Driven0.594%0.000%324,62102023-07-31
USAA Science & Technology0.477%-5.082%256,608-13,7382022-09-30
Heptagon Driehaus US Sm Cp Eq X1 USD Acc0.459%4.473%247,86610,6132023-03-31
Destinations Small-Mid Cap Equity I0.444%-1.683%239,905-4,1072023-04-30
Fidelity® Extended Market Index0.419%0.000%226,00402023-02-28
Driehaus Small Cap Growth Institutional0.403%-2.529%216,645-5,6222022-11-30

Discussions

Please log in or register to share your thoughts.

born_to_be_kob

$CRNX this is my only green stonk!

I really like this stonk.

0 Like Report
dogefan77

$CRNX who else finds themselves here after liquidating their positions for a loss only to bash on how seriously fcked up the stock market is

0 Like Report